“…In a first approach, this optimization has been done by the empirical testing of newly synthesized lipids that had never been used before for gene therapy applications, and that led to the appearance of some promising lipoid molecules such as the gemini (dimeric) surfactants [3,4], the PEGylated (stealth) lipids [5,6], the pH-sensitive amphiphiles [7,8], the amino acidderived surfactants [9,10], or the neutral (helper) lipids [11,12]. Simultaneously, the increasing understanding of the transfection mechanism has led the researchers to explore the highly tunable physicochemical properties of lipoplexes (namely size [13,14], surface charge [15,16], curvature [17,18] and membrane fluidity [13]) as a means of enhancing transfection efficiency.…”